Abstract
The purpose was evaluating retrospectively the additional value of integrated positron emission tomography (PET) and computed tomography (CT) in the detection of pulmonary metastases in comparison with CT and PET alone. Fifty-six lung nodules, divided into three groups according their size, detected in 24 consecutive patients with a known primary tumor were retrospectively evaluated with integrated PET-CT, CT and PET. The nature of these nodules was determined by either histopathology or a follow-up of at least 6 months. The CT and PET images of the integrated PET-CT were evaluated separately by a radiologist and a nuclear medicine physician, the integrated PET-CT images were evaluated by a chest radiologist and nuclear medicine physician in consensus. The investigators were asked to search lung nodules and to determine whether these nodules were metastases or not. Sensitivity and accuracy for CT, PET and integrated PET-CT for characterization of all pulmonary nodules were, respectively: 100%, 90%, 100% and 57%, 55%, 55%. There was no significant difference in the characterization of pulmonary nodules between integrated PET-CT and CT alone (P=1.000) and PET alone (P=0.1306). An accurate evaluation is only possible for lesions larger than 1 cm.
Similar content being viewed by others
References
The International Registry of Lung Metastases (1997) Long-term results of lung metastasectomy: prognostic analyses based on 5,206 cases. J Thorac Cardiovasc Surg 113:37–49
Rusch V (1995) Pulmonary metastasectomy: current indications. Chest 107:322S–332S
Diederich S, Semik M, Lentschig MG, Winter F, Scheld HH, Roos N, Bongartz G (1999) Helical CT of pulmonary nodules in patients with extrathoracic malignancy: CT-surgical correlation. AJR Am J Roentgenol 172:353–360
Muhm JR, Brown LR, Crowe JK (1977) Detection of pulmonary nodules by computed tomography. AJR Am J Roentgenol 128:267–270
Scott WJ, Schwabe JL, Gupta NC et al (1994) Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F] fluorodeoxyglucose. Ann Thorac Surg 58:698–703
Gambhir SS, Shepherd JE, Shah BD et al (1998) Analytical decision model for the cost-effectiveness management of solitary pulmonary nodules. J Clin Oncol 16:2113–2125
Vansteenkiste JF, Stroobants SG (2001) The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur Respir J 17:808–820
Patz EF, Lowe VJ, Hoffman JM et al (1993) Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188:487–490
Dewan NA, Gupta NC, Redepenning LS et al (1993) Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 104:997–1002
Higashi K, Ueda Y, Seki H et al (1998) Fluorine-18-FDG PET imaging is negative in bronchioloalveolar carcinoma. J Nucl Med 39:1016–1020
Imdahl A, Jenkner S, Brink I, et al (2001) Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardio-Thoracic Surg 20:324–329
Townsend DW, Beyer T, Blodgett TM (2003) PET/CT scanners: a hardware approach to image fusion. Semin Nucl Med 33:193–204
Diederich S, Hansen J, Wormanns D (2005) Resolving small pulmonary nodules: CT features. Eur Radiol 15:2064–2069
Ginsberg MS, Griff SK, Go BD, Yoo HH, Schwartz LH, Panicek DM (1999) Pulmonary nodules resected at video-assisted thoracoscopic surgery: etiology in 426 patients. Radiology 213:277–284
Chang AE, Schaner EG, Conkle DM, Flye MW, Doppman JL, Rosenberg SA (1979) Evaluation of computed tomography in the detection of pulmonary metastases: a prospective study. Cancer 43:913–916
Lund G, Heilo A (1982) Computed tomography of pulmonary metastases. Acta Radiol 23:617–620
Juergens KU, Weckesser M, Stegger L, Franzius C, Beetz M, Schober O, Heinder W, Wormanns D (2006) Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules? Eur Radiology 16:1131–1137
Goerres GW, Burger C, Kamel E, Seifert B, Kaim AH, Buck A, Buehler TC, von Schulthess GK (2003) Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 226:906–910
Lee J, Aronchick JM, Alavi A (2001) Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review.Chest 120:1791–1797
Hubner KF, Buonocore E, Singh SK, et al (1995) Characterization of chest masses by FDG-positron emission tomography. Clin Nucl Med 20:293–298
Knight SB, Delbeke D, Stewart JR, et al (1996) Evaluation of pulmonary lesions with FDG-PET: comparison of findings in patients with and without a history of prior malignancy. Chest 109:982–988
Higashi K, Ueda Y, Seki H, et al (1998) Fluorine-18-FDG PET imaging is negative in bronchoalveolar lung carcinoma. J Nucl Med 39:1016–1020
Kim BT, Kim Y, Lee KS, et al (1998) Localized form of bronchoalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 170:935–939
Patz EF, Lowe VJ, Hoffman JM, et al (1993) Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188:487–490
Gupta NC, Frank AR, Dewan NA et al (1992) Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 184:441–444
Hubner KF, Buonocore E, Gould HR et al (1996) Differentiating benign from malignant lung lesions using “quantitative” parameters of FDG-PET images. Clin Nucl Med 21:941–949
Fischer BM, Mortensen J, Dirksen A, Eigtved A, Hojgaard L (2004) Positron emission tomography of incidentally detected small pulmonary nodules.Nucl Med Commun 25:3–9
Kernstine KH, Grannis FW Jr, Rotter AJ (2005) Is there a role for PET in the evaluation of subcentimeter pulmonary nodules? Semin Thorac Cardiovasc Surg Summer; 17:110–114
Reinhardt MJ, Wiethoelter N, Matthies A, Joe AY, Strunk H, Jaeger U, Biersack HJ (2006) PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images.Eur J Nucl Med Mol Imaging 33:134–139
Kamel E, Hany TF, Burger C et al (2002) CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging 29:346–350
Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK (2002) PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 225:575–581
Wormanns D, Ludwig K, Beyer F, Heindel W, Diederich S (2005) Detection of pulmonary nodules at multirow-detector CT: effectiveness of double reading to improve sensitivity at standard-dose and low-dose chest CT. Eur Radiol 15:14–22
Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF (2004) To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 45 (Suppl 1):56S–65S
Yau YY, Chan WS, Tam YM, Vernon P, Wong S, Coel M, Chu SK (2005) Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? J Nucl Med 46:283–291
Dizendorf E, Hany TF, Buck A, Von Schulthess GK, Burger C (2003) Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med 44:732–738
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Wever, W., Meylaerts, L., De Ceuninck, L. et al. Additional value of integrated PET-CT in the detection and characterization of lung metastases: correlation with CT alone and PET alone. Eur Radiol 17, 467–473 (2007). https://doi.org/10.1007/s00330-006-0362-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-006-0362-7